NASDAQ: VERU

Veru Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Veru Inc. (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Veru investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than February 6, 2023.

If you purchased Veru, Inc. securities during the Class Period and would like to join the action, please click “Join This Class Action.”

Class Period:May 11, 2022 through November 9, 2022

If you purchased Veru Inc. (VERU) securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements regarding the Company’s:

data from the sabizabulin Phase 3 trial and the Company’s interactions with the FDA;
statements misleading its shareholders to believe that the data from the Phase 3 trial was sufficient to support Emergency Use Authorization (“EUA”) and even the submission of a New Drug Application (“NDA”) without any further studies; and
filings which concealed the true risks faced by the Company in gaining approval for its EUA request

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.